These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2226627)

  • 1. Opposite effects of endothelin-1 and Big-endothelin-(1-39) on renal function in rats.
    Hoffman A; Grossman E; Keiser HR
    Eur J Pharmacol; 1990 Jul; 182(3):603-6. PubMed ID: 2226627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic-natriuretic actions and pressor effects of big-endothelin (1-39) in phosphoramidon-treated rats.
    Hoffman A; Haramati A; Dalal I; Shuranyi E; Winaver J
    Proc Soc Exp Biol Med; 1994 Feb; 205(2):168-73. PubMed ID: 8108467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
    Pollock DM; Opgenorth TJ
    Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat.
    Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
    Life Sci; 1994; 55(16):1285-91. PubMed ID: 7934630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.
    Pollock DM; Opgenorth TJ
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R257-63. PubMed ID: 1650147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelin ET(B) receptors in the renal hemodynamic and excretory responses to big endothelin-1.
    Konishi F; Okada Y; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
    Eur J Pharmacol; 2002 Sep; 451(2):177-84. PubMed ID: 12231389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
    Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
    Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action.
    Poulat P; D'Orléans-Juste P; de Champlain J; Yano M; Couture R
    Brain Res; 1994 Jun; 648(2):239-48. PubMed ID: 7522926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin.
    Le Monnier de Gouville AC; Cavero I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S362-5. PubMed ID: 1725381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats.
    Matsumura Y; Fujita K; Takaoka M; Morimoto S
    Eur J Pharmacol; 1993 Jan; 230(1):89-93. PubMed ID: 8094056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of big endothelin-1 in experimental congestive heart failure.
    Gurbanov K; Winaver J; Haramati A; Hoffman A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S473-5. PubMed ID: 8587450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1.
    Corder R; Vane JR
    Biochem Pharmacol; 1995 Jan; 49(3):375-80. PubMed ID: 7857324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
    Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
    Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
    Pollock DM
    Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.
    Matsumura Y; Hisaki K; Takaoka M; Morimoto S
    Eur J Pharmacol; 1990 Aug; 185(1):103-6. PubMed ID: 2226629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
    Le Monnier de Gouville AC; Cavero I
    Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
    Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
    Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1993 Dec; 110(4):1532-6. PubMed ID: 8306098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.